House Bill 1026
117th Congress(2021-2022)
LABEL Opioids Act
Introduced
Introduced in House on Feb 11, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1026
Congress
117
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Greg Stanton
grade
Arizona
Arizona
California
Connecticut
Nebraska
New Jersey
North Carolina
Pennsylvania
Washington
No House votes have been held for this bill.
Summary
Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act
This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.
February 11, 2021
04/28/2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
02/12/2021
Referred to the Subcommittee on Health.
02/11/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
02/11/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:47:25 PM